by Editorial | Apr 29, 2020 | 2020 News, World Pharma Today
Genalyte’s U.S. Food and Drug Administration (FDA)-cleared Maverick™ Diagnostic System will expand antibody testing in the fight against COVID-19 with the launch of its SARS-CoV-2 Multi-Antigen Serology Panel. The antibody test and results represent a crucial step in...
by Editorial | Apr 29, 2020 | 2020 News, iMicroNews
First instrument-based, rapid test uses multi-antigen approach to achieve best-in-class sensitivity and specificity, U.S. FDA EUA submitted. Genalyte, the company empowering physicians and patients with real-time diagnostics and healthcare analytics, announced today...
by Chloe Kent | Apr 28, 2020 | 2020 News, Medical Device Network
Genalyte has announced that its rapid Covid-19 serology panel is available on its Maverick platform. The SARS-CoV-2 Multi-Antigen Serology Panel detects the presence of IgG and IgM antibodies, which are produced in bodies when infected by the SARS-CoV-2 virus that...
by Editorial | Apr 28, 2020 | 2020 News, MPO Magazine
Genalyte’s U.S. Food and Drug Administration (FDA)-cleared Maverick Diagnostic System will expand antibody testing in the fight against COVID-19 with the launch of its SARS-CoV-2 Multi-Antigen Serology Panel. The antibody test and results represent a crucial...
by Editorial | Apr 28, 2020 | 2020 News, Contract Pharma
Genalyte Inc. has made available its rapid COVID-19 serology panel on its Maverick platform. The panel tests for the detection of IgG and IgM antibodies that the body produces in response to the novel coronavirus (SARS-CoV-2). READ MORE
Recent Comments